Article
Spectral-domain optical coherence tomography in subjects over 60-years-old and its implications for designing clinical trials
Search Medline for
Authors
Published: | May 30, 2012 |
---|
Outline
Text
Aims: To study the variability of central retinal thickness (CRT), its concordance to the fellow eyes, and the implications for designing future clinical trials using spectral-domain optical coherence tomography (SD-OCT).
Methods: Cross sectional retrospective analysis of European Genetic Database (EUGENDA). Six hundred thirty two eyes of 316 subjects over 60 years old without macular pathology were examined using SD-OCT.
Results: Mean CRT was 280.22 µm and 281.02 µm for the right and left eyes, respectively. There was a strong concordance for all measured values between right and left eyes. Men had significantly thicker CRT than women. Variation up to 23 µm difference between both eyes was seen. To detect a change of at least 30 µm in CRT, a sample size of 90 or 176 per group is needed for a single or double arm study, respectively (α=0.05, power=0.80, no loss to follow up, assuming standard deviation in future studies=100 µm).
Conclusions: Clinical trials using CRT as an endpoint are feasible in terms of sample size needed.